Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Magnetic resonance imaging studies of cigarette smoking.

Azizian A, Monterosso J, O'Neill J, London ED.

Handb Exp Pharmacol. 2009;(192):113-43. doi: 10.1007/978-3-540-69248-5_5. Review.

PMID:
19184648
2.

Human functional neuroimaging in nicotine and tobacco research: basics, background, and beyond.

McClernon FJ, Gilbert DG.

Nicotine Tob Res. 2004 Dec;6(6):941-59. Review. Erratum in: Nicotine Tob Res. 2005 Apr;7(2):307.

PMID:
15801569
4.

The neurobiological and neurocognitive consequences of chronic cigarette smoking in alcohol use disorders.

Durazzo TC, Gazdzinski S, Meyerhoff DJ.

Alcohol Alcohol. 2007 May-Jun;42(3):174-85. Review.

PMID:
17526627
5.

Nicotine and tobacco dependence: normalization or stimulation?

Domino EF.

Alcohol. 2001 Jun;24(2):83-6. Review.

PMID:
11522427
6.

Smoking, nicotine and neuropsychiatric disorders.

Dome P, Lazary J, Kalapos MP, Rihmer Z.

Neurosci Biobehav Rev. 2010 Mar;34(3):295-342. doi: 10.1016/j.neubiorev.2009.07.013. Epub 2009 Aug 7. Review.

PMID:
19665479
7.

The neuronal pathways mediating the behavioral and addictive properties of nicotine.

Balfour DJ.

Handb Exp Pharmacol. 2009;(192):209-33. doi: 10.1007/978-3-540-69248-5_8. Review.

PMID:
19184651
8.

In vivo brain imaging of human exposure to nicotine and tobacco.

Sharma A, Brody AL.

Handb Exp Pharmacol. 2009;(192):145-71. doi: 10.1007/978-3-540-69248-5_6. Review.

9.

Cigarette smoking and nicotine dependence.

Zbikowski SM, Swan GE, McClure JB.

Med Clin North Am. 2004 Nov;88(6):1453-65, x. Review.

PMID:
15464107
10.

Rodent models of nicotine withdrawal syndrome.

Malin DH, Goyarzu P.

Handb Exp Pharmacol. 2009;(192):401-34. doi: 10.1007/978-3-540-69248-5_14. Review.

PMID:
19184657
11.

Nicotine self-medication of cognitive-attentional processing.

Evans DE, Drobes DJ.

Addict Biol. 2009 Jan;14(1):32-42. doi: 10.1111/j.1369-1600.2008.00130.x. Epub 2008 Oct 9. Review.

PMID:
18855804
12.

Serotonin receptors as potential targets for modulation of nicotine use and dependence.

Fletcher PJ, LĂȘ AD, Higgins GA.

Prog Brain Res. 2008;172:361-83. doi: 10.1016/S0079-6123(08)00918-7. Review.

PMID:
18772042
13.

[A review of the effects of nicotine on schizophrenia].

Bidzan L.

Psychiatr Pol. 2007 Sep-Oct;41(5):737-44. Review. Polish.

PMID:
18421928
14.

Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences.

Poorthuis RB, Goriounova NA, Couey JJ, Mansvelder HD.

Biochem Pharmacol. 2009 Oct 1;78(7):668-76. doi: 10.1016/j.bcp.2009.04.031. Epub 2009 May 6. Review.

PMID:
19426718
15.

Importance of nonpharmacological factors in nicotine self-administration.

Caggiula AR, Donny EC, Chaudhri N, Perkins KA, Evans-Martin FF, Sved AF.

Physiol Behav. 2002 Dec;77(4-5):683-7. Review.

PMID:
12527019
16.

Altered amygdala function in nicotine addiction: insights from human neuroimaging studies.

Mihov Y, Hurlemann R.

Neuropsychologia. 2012 Jul;50(8):1719-29. doi: 10.1016/j.neuropsychologia.2012.04.028. Epub 2012 May 7. Review.

PMID:
22575084
17.

Functional magnetic resonance and spectroscopy in drug and substance abuse.

Magalhaes AC.

Top Magn Reson Imaging. 2005 Jun;16(3):247-51. Review.

PMID:
16340649
18.

The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction?

Balfour DJ, Ridley DL.

Pharmacol Biochem Behav. 2000 May;66(1):79-85. Review.

PMID:
10837846
19.

Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans.

Jasinska AJ, Zorick T, Brody AL, Stein EA.

Neuropharmacology. 2014 Sep;84:111-22. doi: 10.1016/j.neuropharm.2013.02.015. Epub 2013 Mar 6. Review.

20.

Functional magnetic resonance imaging of cholinergic modulation in mild cognitive impairment.

Dickerson BC.

Curr Opin Psychiatry. 2006 May;19(3):299-306. Review.

PMID:
16612217

Supplemental Content

Support Center